We demonstrated that talniflumate pre-treatment of organoids increases the recognition of tumor cells by immune cells (Additional file 4: Figure S4a, red), apoptosis (Additional file 4: Figure S4a, green) and T lymphocytes activation (CD8+/CD25+) (Additional file 4: Figure S4b). This evidence concerns the gene CD8A and neoplasm.